Dr Jyoti Choithani Ramani analyses Taiho Pharmaceutical Co. Ltd. v. Controller of Patents & Anr., where the Delhi High Court set aside the rejection of Taiho’s patent. The Court clarified
In a landmark case, Gilead Pharmasset, LLC v Sankalp Rehabilitation Trust and Ors., the Indian Patent Office (IPO) in Kolkata granted a patent to Gilead Pharmasset, LLC (Gilead), covering the
In Chugai Seiyaku Kabushiki Kaisha and Hoffmann-La Roche AG v Frensenius Kabi Oncology Limited and Fresensius Kabi India Private Limited, the plaintiff, Chugair Seiyaku Kabushiki Kaisha (CSKK) sought a permanent
The abolishment of the Intellectual Property Appellate Board (IPAB) through the Tribunals Reforms Act, 2021 brought about a period of uncertainty in Read Full Article ABOUT THE AUTHOR Dr. Jyoti
In Novartis AG v Controller of Patents and Designs, the Delhi High Court dealt yet again with the validity of divisional applications considering the issue of plurality of distinct inventions.
Oligonucleotide microarray has emerged as a powerful tool to efficiently address various problems in molecular biology and medical sciences [1–3]. The technique allows simultaneous detection of many different targets in
The Himachal Pradesh High Court recently issued ad-interim injunctions to a patentee, Boehringer Ingelheim (BI), against five Indian generic companies (the defendants). BI filed separate infringement suits against the companies
As per the rules of the Bar Council of India, we are not permitted to solicit work and advertise. By clicking on the “I AGREE” button below, you acknowledge the following:
The information provided under this website is solely available at your request for informational purposes only, should not be interpreted as soliciting or advertisement. We are not liable for any consequence of any action taken by the user relying on material / information provided under this website. In cases where the user has any legal issues, he/she in all cases must seek independent legal advice.
